Literature DB >> 14716728

Selecting pre-screening items for early intervention trials of dementia--a case study.

Lang Li1, Jeffrey Huang, Sharon Sun, Jianzhao Shen, Frederick W Unverzagt, Sujuan Gao, Hugh H Hendrie, Kathleen Hall, Siu L Hui.   

Abstract

Our goal was to review and extend statistical methods for discriminating between normal subjects and those with dementia or cognitive impairment. We compared six different methods to one constructed by expert opinion, in their brevity and predictive power. The methods include logistic regression and neural networks, with standard and least absolute shrinkage and selection operator (LASSO) variable selection, as well as decision trees with and without boosting. These methods were applied to the baseline data of a subgroup of subjects in a dementia study, using their screening interview items to predict their clinical diagnosis of normal or non-normal (cognitively impaired or demented). The derived models were then validated on a different subgroup of subjects in the same study who had the screening and clinical diagnosis two to five years later. Performance of different models was compared based on their sensitivity and specificity in the validation sample. Generally, the six statistical methods performed slightly to moderately better than the expert-opinion model. Neural networks generally performed better than the logistic and decision tree models. LASSO improved the performance of logistic and neural network models, but it eliminated few input variables in the neural network. The single decision tree performed at least as well as the standard logistic model, and with fewer items, making it an attractive pre-screening tool. Using the boosting option for decision trees did not substantially improve the performance. We recommend that for each situation, different methods of classification should be attempted to obtain optimal results for a given purpose. Copyright 2004 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2004        PMID: 14716728     DOI: 10.1002/sim.1715

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  3 in total

1.  The challenge for genetic epidemiologists: how to analyze large numbers of SNPs in relation to complex diseases.

Authors:  A Geert Heidema; Jolanda M A Boer; Nico Nagelkerke; Edwin C M Mariman; Daphne L van der A; Edith J M Feskens
Journal:  BMC Genet       Date:  2006-04-21       Impact factor: 2.797

2.  CCL3L1-CCR5 genotype improves the assessment of AIDS Risk in HIV-1-infected individuals.

Authors:  Hemant Kulkarni; Brian K Agan; Vincent C Marconi; Robert J O'Connell; Jose F Camargo; Weijing He; Judith Delmar; Kenneth R Phelps; George Crawford; Robert A Clark; Matthew J Dolan; Sunil K Ahuja
Journal:  PLoS One       Date:  2008-09-08       Impact factor: 3.240

3.  The subtype-specific molecular function of SPDEF in breast cancer and insights into prognostic significance.

Authors:  Ting Ye; Jingyuan Li; Jia Feng; Jinglan Guo; Xue Wan; Dan Xie; Jinbo Liu
Journal:  J Cell Mol Med       Date:  2021-06-30       Impact factor: 5.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.